| Sun-Kissed or Sunburned? A health columnist who loves to tan asks if it's possible to enjoy the sun in moderation. online.wsj.com |
Onyx Pharma, Bayer Have Yet to Prove Utility of Cancer Drug EP Vantage submits:Try as they might, Bayer (BAYRY.PK) and Onyx Pharmaceuticals (ONXX) have been struggling for some time to prove that Nexavar has a role beyond liver and kidney cancer. Therefore news that the drug has failed in a second phase III lung cancer study is hardly encouraging. Despite these two failed trials, executives at Onyx Pharmaceuticals struck an upbeat note on a conference call Monday, pointing to upcoming data in breast cancer and another lung cancer trial in a different setting, and expressing confidence that additional tumor types are within the kinase inhibitor’s grasp. However, with Onyx having invested heavily in this quest, at the expense of profitability, good news is needed to restore some flagging confidence (Onyx needs to find Nexavar growth as another quarter disappoints, April 30, 2010).Complete Story » seekingalpha.com |
Cord Blood America CEO Matthew Schissler in Analyst Interview Explains Continuing Education Course for Nurses (PR Newswire) Cord Blood America, Inc. announced today that it has begun its continuing education program for the nation's 2.9 million registered nurses on the value of cord blood collection as a potentially life-saving resource for treating serious diseases. us.rd.yahoo.com |
Cord Blood America Says Placenta Collection Services Increasing Revenues in Third Quarter; July 2010 Top Month in Year; BioCells, Inc. Acquisition Proceeding to September Closing [PR Newswire] - Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that placenta collection services in the third quarter of 2010 for a well-respected, accredited, tissue bank have increased by 40 percent so far compared to the second quarter of 2010, to a total of more than $35,000 in revenues through July and August of 2010. us.rd.yahoo.com |
Beetles Prompt Similac Recall Abbott is recalling about five million containers of Similac powdered baby formula as the company learned that beetles or their larvae could be in the product. online.wsj.com |